Chugai Pharmaceutical Co., Ltd. (Japan)

本机构学者在这里署名、按本站篇数

合作机构同一篇文章里的其他机构

1. Wakayama Medical University日本2
2. Kanagawa Cancer Center1
3. National Institute of Occupational Safety and Health日本1
4. Genentech1
5. National Hospital Organization Kyushu Cancer Center日本1
6. Tokyo University of Science日本1
7. F. Hoffmann-La Roche AG瑞士1
8. The University of Tokyo日本1

按月发文

逐年被引

最新文献

1. 1
   Evaluation of Data Quality and Utility of the Japan Drug Information Institute in Pregnancy (JDIIP) Consultation Case Database for Pregnancy PharmacovigilanceDrug Safety20250
2. 2
   Erlotinib Plus Bevacizumab Phase ll Study in Patients with Advanced Non-small-Cell Lung Cancer (JO25567): Updated Safety ResultsDrug Safety201758
3. 3
   Effects of web-based stress and depression literacy intervention on improving work engagement among workers with low work engagement: An analysis of secondary outcome of a randomized controlled trialJournal of Occupational Health201622

高被引文献

1. 1
   Erlotinib Plus Bevacizumab Phase ll Study in Patients with Advanced Non-small-Cell Lung Cancer (JO25567): Updated Safety ResultsDrug Safety201758
2. 2
   Effects of web-based stress and depression literacy intervention on improving work engagement among workers with low work engagement: An analysis of secondary outcome of a randomized controlled trialJournal of Occupational Health201622

主要发表期刊